Open access
Open access
Powered by Google Translator Translator

Cohort Study | Comparative safety of antiseizure medication monotherapy in pregnancy for major malformations.

9 Dec, 2022 | 13:10h | UTC

Comparative safety of antiseizure medication monotherapy for major malformations – Annals of Neurology (link to abstract – $ for full-text)

Commentary: Children Exposed to Valproate and Topiramate Before Birth at Higher Risk of Major Congenital Malformations – Neurology Today

Related:

Risks of 23 Specific Malformations Associated with Prenatal Exposure to 10 Antiepileptic Drugs

Research: Topiramate Use Early in Pregnancy and the Risk of Oral Clefts

Cohort Study: Association of prenatal exposure to antiseizure medication with risk of autism and intellectual disability.

Diagnosis and management of individuals with Fetal Valproate Spectrum Disorder; a consensus statement from the European Reference Network for Congenital Malformations and Intellectual Disability – Orphanet Journal of Rare Diseases

Thirteen UK healthcare bodies launch ‘pragmatic’ guidance on valproate use – Royal College of General Practitioners

Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Risk for Attention-Deficit/Hyperactivity Disorder in Offspring – JAMA Network Open

Educational attainment of children born to mothers with epilepsy – Journal of Neurology, Neurosurgery, and Psychiatry (link to abstract – $ for full-text)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.